Polaris Venture Partners

presented by
presented by
News

Trevena grabs $35M to fund trials of heart-failure drug

Trevena Inc. has landed a sizable $35 million Series B round that it hopes will push its lead heart-failure drug through Phase 2 clinical trials. The funding was led by venture heavyweights and existing investors Polaris Venture Partners and New Enterprise Associates. Other previous investors — Alta Partners, Healthcare Ventures and Yasuda Enterprise Development Company […]

presented by
News

Polaris Venture Partners raises $233M of $400M fund

Life sciences and IT investment firm Polaris Venture Partners has raised $233 million of an anticipated $400 million fund, according to a filing with the Securities and Exchange Commission. The $400 million goal appears to represent scaled-down expectations for the venture luminary, which had previously targeted $500 million for its sixth fund, VentureWire reported. Polaris’ […]

News

Apnex Medical names former BSX and J&J executive as its new CEO

Apnex Medical Inc., a St. Paul-based startup developing technology to treat obstructive sleep apnea (OSA), has named Charles McKhann as its new CEO. McKhann, who previously served as a global vice president of marketing for Boston Scientific Corp.’s (NYSE: BSX) cardiac rhythm management division, replaces founder and executive director Robert Atkinson. While at Johnson & […]